LYNX: A Novel Mobile App to Support Linkage to HIV/STI Testing PrEP for Young Men Who Have Sex With Men

Completed · Not applicable

Conditions studied: HIV, Sexually Transmitted Diseases, Risk Reduction, Pre-Exposure Prophylaxis

In brief

This study is testing the acceptability and feasibility of a highly interactive mobile application (app) to promote HIV/sexually transmitted infection (STI) testing and uptake of pre-exposure prophylaxis (PrEP) among young men who have sex with men (YMSM).

Key facts

Study ID

NCT03177512

Run by

Public Health Foundation Enterprises, Inc.

People needed

61

Starts

2018-10-25

Expected to finish

2019-11-18

Last updated by the study team

2021-05-11

Who can join

Age: 15 and older, up to 24. Sex: male. Healthy volunteers: accepted.

You may qualify if…

• No HIV test in the past 3 months (self-reported).
• Not known to be HIV-infected (self-reported).
• Not currently taking PrEP (self-reported).
• Owns an Apple operating system (iOS) or Android mobile phone and willing and able to download the LYNX app onto their phone.
• Willing and able to attend an in-person baseline visit in the Tampa or Chicago area.
• Able to understand, read, and speak English.
• Participants ages 15-18: self-report at least one episode of anal intercourse with a male or transfemale partner during the last 6 months
• Participants ages 19-24: self-report evidence of high risk for acquiring HIV infection including at least one of the following:
• at least one episode of condomless anal sex with an HIV-positive or unknown HIV status male or transfemale partner during the last 6 months; or
• Anal sex with 2 or more male and/or transfemale partners during the last 6 months; or
• Exchange of money, gifts, shelter, or drugs for anal sex with a male or transfemale partner during the last 6 months; or
• Sex with a male or transfemale partner and has had an STI during the last 6 months.

You may not qualify if…

• Currently enrolled in another HIV intervention study
• Prior enrollment in an HIV vaccine trial with receipt of experimental vaccine product
• Enrollment in an earlier phase of LYNX study
• Any medical, psychiatric, or social condition or other responsibilities that, in the judgment of the investigator, would make participation in the study unsafe, complicate interpretation of study outcome data, or otherwise interfere with achieving the study objectives.

Where it is running

• University of South Florida, Department of Pediatrics — Tampa, Florida, United States
• The CORE Center, Cook County Health and Hospitals System — Chicago, Illinois, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.